Variant report

Variant	esv3324286
Chromosome Location	chr16:83028451-83032749
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	CEBPB	chr16:83031682-83031837	HepG2	liver:	n/a	n/a
2	CEBPB	chr16:83029843-83030177	IMR90	lung:	n/a	n/a
3	CTCF	chr16:83030539-83030650	Fibrobl	skin:	n/a	n/a
4	CTCF	chr16:83030585-83030772	GM19239	blood:	n/a	n/a
5	CTCF	chr16:83030597-83030704	MCF-7	breast:	n/a	n/a
6	CTCF	chr16:83030367-83030450	GM19239	blood:	n/a	n/a
7	CTCF	chr16:83030429-83030440	MCF-7	breast:	n/a	n/a
8	CTCF	chr16:83030747-83030769	MCF-7	breast:	n/a	n/a
9	EP300	chr16:83029831-83030072	SK-N-SH_RA	brain:	n/a	chr16:83029864-83029878 chr16:83029867-83029881 chr16:83029865-83029879 chr16:83029917-83029926
10	EP300	chr16:83029723-83030110	SK-N-SH_RA	brain:	n/a	chr16:83029864-83029878 chr16:83029867-83029881 chr16:83029865-83029879 chr16:83029917-83029926
11	FOS	chr16:83029743-83030119	MCF10A-Er-Src	breast:	n/a	chr16:83029917-83029924 chr16:83029917-83029925 chr16:83029915-83029927 chr16:83029917-83029926 chr16:83029915-83029926
12	FOS	chr16:83028804-83030166	HUVEC	blood vessel:	n/a	chr16:83029380-83029389 chr16:83029917-83029924 chr16:83029917-83029925 chr16:83029915-83029927 chr16:83029917-83029926 chr16:83029915-83029926
13	FOS	chr16:83029621-83030090	MCF10A-Er-Src	breast:	n/a	chr16:83029917-83029924 chr16:83029917-83029925 chr16:83029915-83029927 chr16:83029917-83029926 chr16:83029915-83029926
14	FOS	chr16:83029662-83030111	MCF10A-Er-Src	breast:	n/a	chr16:83029917-83029924 chr16:83029917-83029925 chr16:83029915-83029927 chr16:83029917-83029926 chr16:83029915-83029926
15	FOS	chr16:83029668-83030117	MCF10A-Er-Src	breast:	n/a	chr16:83029917-83029924 chr16:83029917-83029925 chr16:83029915-83029927 chr16:83029917-83029926 chr16:83029915-83029926
16	FOSL2	chr16:83029218-83030204	SK-N-SH	brain:	n/a	chr16:83029916-83029927 chr16:83029380-83029389 chr16:83029917-83029924 chr16:83029917-83029925 chr16:83029915-83029927 chr16:83029917-83029926
17	FOSL2	chr16:83029642-83030080	SK-N-SH	brain:	n/a	chr16:83029916-83029927 chr16:83029917-83029924 chr16:83029917-83029925 chr16:83029915-83029927 chr16:83029917-83029926
18	FOSL2	chr16:83029849-83030032	HepG2	liver:	n/a	chr16:83029916-83029927 chr16:83029917-83029924 chr16:83029917-83029925 chr16:83029915-83029927 chr16:83029917-83029926
19	FOSL2	chr16:83029784-83030142	HepG2	liver:	n/a	chr16:83029916-83029927 chr16:83029917-83029924 chr16:83029917-83029925 chr16:83029915-83029927 chr16:83029917-83029926
20	GATA2	chr16:83028902-83030180	HUVEC	blood vessel:	n/a	chr16:83029400-83029411 chr16:83029398-83029407 chr16:83029230-83029237 chr16:83029813-83029823 chr16:83029626-83029637
21	GATA3	chr16:83029173-83030253	SK-N-SH	brain:	n/a	chr16:83029400-83029411 chr16:83029398-83029407 chr16:83029230-83029237 chr16:83029813-83029823 chr16:83029626-83029637
22	GATA3	chr16:83029104-83030306	SK-N-SH	brain:	n/a	chr16:83029400-83029411 chr16:83029398-83029407 chr16:83029230-83029237 chr16:83029813-83029823 chr16:83029626-83029637
23	JUN	chr16:83031680-83031716	HepG2	liver:	n/a	n/a
24	JUN	chr16:83028911-83030119	HUVEC	blood vessel:	n/a	chr16:83029380-83029389 chr16:83029917-83029924 chr16:83029917-83029925 chr16:83029915-83029927 chr16:83029917-83029926
25	JUND	chr16:83029252-83030201	SK-N-SH	brain:	n/a	chr16:83029915-83029926 chr16:83029380-83029389 chr16:83029917-83029924 chr16:83029917-83029925 chr16:83029915-83029927 chr16:83029917-83029926
26	JUND	chr16:83028227-83030884	SK-N-SH	brain:	n/a	chr16:83029915-83029926 chr16:83029380-83029389 chr16:83029917-83029924 chr16:83029917-83029925 chr16:83029915-83029927 chr16:83029917-83029926
27	JUND	chr16:83029764-83030080	HepG2	liver:	n/a	chr16:83029915-83029926 chr16:83029917-83029924 chr16:83029917-83029925 chr16:83029915-83029927 chr16:83029917-83029926
28	JUND	chr16:83029262-83030249	SK-N-SH	brain:	n/a	chr16:83029915-83029926 chr16:83029380-83029389 chr16:83029917-83029924 chr16:83029917-83029925 chr16:83029915-83029927 chr16:83029917-83029926
29	KAP1	chr16:83029249-83030171	U2OS	brain:	n/a	chr16:83029918-83029927
30	MAFK	chr16:83029543-83029958	IMR90	lung:	n/a	chr16:83029918-83029927 chr16:83029917-83029927
31	MYC	chr16:83030729-83030784	MCF-7	breast:	n/a	n/a
32	MYC	chr16:83030635-83030645	MCF-7	breast:	n/a	n/a
33	MYC	chr16:83030666-83030787	MCF-7	breast:	n/a	n/a
34	MYC	chr16:83029908-83030025	HUVEC	blood vessel:	n/a	chr16:83029917-83029926 chr16:83029916-83029925
35	MYC	chr16:83030595-83030726	MCF-7	breast:	n/a	n/a
36	MYC	chr16:83029766-83030003	MCF10A-Er-Src	breast:	n/a	chr16:83029917-83029926 chr16:83029916-83029925
37	NFIC	chr16:83029316-83030177	SK-N-SH	brain:	n/a	n/a
38	POLR2A	chr16:83030035-83030056	HUVEC	blood vessel:	n/a	n/a
39	POLR2A	chr16:83031603-83031765	MCF10A-Er-Src	breast:	n/a	n/a
40	POLR2A	chr16:83030519-83030825	H1-hESC	embryonic stem cell:	n/a	n/a
41	POLR2A	chr16:83029748-83030095	SK-N-SH	brain:	n/a	n/a
42	POLR2A	chr16:83029344-83030093	HUVEC	blood vessel:	n/a	n/a
43	POLR2A	chr16:83029676-83029946	MCF10A-Er-Src	breast:	n/a	n/a
44	POLR2A	chr16:83029968-83029990	MCF10A-Er-Src	breast:	n/a	n/a
45	POLR2A	chr16:83028816-83030284	HUVEC	blood vessel:	n/a	n/a
46	POLR2A	chr16:83029823-83030156	PFSK-1	brain:	n/a	n/a
47	POLR2A	chr16:83029736-83030134	HUVEC	blood vessel:	n/a	n/a
48	POLR2A	chr16:83029138-83030230	HUVEC	blood vessel:	n/a	n/a
49	RAD21	chr16:83029844-83030120	SK-N-SH_RA	brain:	n/a	n/a
50	RAD21	chr16:83029858-83030037	SK-N-SH_RA	brain:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr16:83029415-83029465	A549	lung:	n/a
2	chr16:83029415-83029465	RPTEC	kidney:	n/a
3	chr16:83029415-83029465	HRCEpiC	kidney:	n/a
4	chr16:83029415-83029465	Jurkat	blood:	n/a
5	chr16:83029415-83029465	NH-A	brain:	n/a
6	chr16:83029415-83029465	HIPEpiC	eye:	n/a
7	chr16:83029415-83029465	AoSMC	blood vessel:	n/a
8	chr16:83029415-83029465	NT2-D1	testis:	n/a
9	chr16:83029415-83029465	HUVEC	blood vessel:	n/a
10	chr16:83029415-83029465	AG10803	skin:	n/a
11	chr16:83029415-83029465	SK-N-SH	brain:	n/a
12	chr16:83029415-83029465	HPAEpiC	pulmonary alveolar:	n/a
13	chr16:83029415-83029465	SK-N-MC	brain:	n/a
14	chr16:83029415-83029465	T-47D	breast:	n/a
15	chr16:83029415-83029465	K562	blood:	n/a
16	chr16:83029415-83029465	SAEC	small airway:	n/a
17	chr16:83029415-83029465	ProgFib	skin:	n/a
18	chr16:83029415-83029465	HCM	heart:	n/a
19	chr16:83029415-83029465	ECC-1	luminal epithelium:	n/a
20	chr16:83029415-83029465	HCT-116	colon:	n/a
21	chr16:83029415-83029465	Hepatocyte	liver:	n/a
22	chr16:83029415-83029465	GM19239	blood:	n/a
23	chr16:83029415-83029465	HRPEpiC	eye:	n/a
24	chr16:83029415-83029465	Caco-2	colon:	n/a
25	chr16:83029415-83029465	BE2_C	brain:	n/a
26	chr16:83029415-83029465	HEK293	kidney:	embryo
27	chr16:83029415-83029465	CMK	blood:	n/a
28	chr16:83029415-83029465	HRE	kidney:	n/a
29	chr16:83029415-83029465	GM12891	blood:	n/a
30	chr16:83029415-83029465	MCF10A-Er-Src	breast:	n/a
31	chr16:83029415-83029465	HEEpiC	esophagus:	n/a
32	chr16:83029415-83029465	U87	brain:	n/a
33	chr16:83029415-83029465	HAEpiC	amniotic membrane:	n/a
34	chr16:83029415-83029465	GM06990	blood:	n/a
35	chr16:83029415-83029465	LNCaP	prostate:	n/a
36	chr16:83029415-83029465	HCF	heart:	n/a
37	chr16:83029415-83029465	MCF-7	breast:	n/a
38	chr16:83029415-83029465	SK-N-SH_RA	brain:	n/a
39	chr16:83029415-83029465	PrEC	prostate:	n/a
40	chr16:83029415-83029465	BJ	skin:	n/a
41	chr16:83029415-83029465	NB4	blood:	n/a
42	chr16:83029415-83029465	NHDF-neo	bronchial:	n/a
43	chr16:83029415-83029465	AG04449	skin:	fetal
44	chr16:83029415-83029465	HepG2	liver:	n/a
45	chr16:83029415-83029465	Hela-S3	cervix:	n/a
46	chr16:83029415-83029465	ovcar-3	ovarian:	n/a
47	chr16:83029415-83029465	HMEC	breast:	n/a
48	chr16:83029415-83029465	AG09309	skin:	n/a
49	chr16:83029415-83029465	H1-hESC	embryonic stem cell:	embryo
50	chr16:83029415-83029465	GM12878	blood:	n/a

Variant related genes	Relation type
ENSG00000260832	TF binding region
ENSG00000260832	CpG island

Extended variants
information (count: 298 )
Associated
traits (count: 74 )

Variant overlapped rSNPs/rCNVs (count:298 , 50 per page) page: 1 2 3 4 5 6

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs541997813	chr16:83028454-83028455	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
2	rs563739236	chr16:83028476-83028477	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs138306839	chr16:83028487-83028488	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs551896763	chr16:83028515-83028516	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs72792140	chr16:83028522-83028523	Weak transcription Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
6	rs531099387	chr16:83028544-83028545	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs544836364	chr16:83028545-83028546	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs142770113	chr16:83028546-83028547	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs146045588	chr16:83028599-83028600	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs199661665	chr16:83028619-83028620	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs561270858	chr16:83028637-83028638	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs565583430	chr16:83028667-83028668	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs191055102	chr16:83028679-83028680	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs182199843	chr16:83028681-83028682	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs78090194	chr16:83028708-83028709	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs368849321	chr16:83028712-83028713	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs536815439	chr16:83028728-83028729	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs556770171	chr16:83028736-83028737	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs570390030	chr16:83028799-83028800	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs539393814	chr16:83028808-83028809	Weak transcription Enhancers Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs79391744	chr16:83028809-83028810	Weak transcription Enhancers Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs148487269	chr16:83028840-83028841	Weak transcription Enhancers Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs74813484	chr16:83028851-83028852	Weak transcription Enhancers Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs555545640	chr16:83028873-83028874	Weak transcription Enhancers Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs372213542	chr16:83028883-83028884	Weak transcription Enhancers Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs544800087	chr16:83028888-83028889	Weak transcription Enhancers Genic enhancers Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs186755843	chr16:83028913-83028914	Weak transcription Enhancers Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
28	rs559022443	chr16:83028918-83028919	Weak transcription Enhancers Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs72792141	chr16:83028936-83028937	Weak transcription Enhancers Genic enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
30	rs569967264	chr16:83028953-83028954	Weak transcription Enhancers Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs190046671	chr16:83028966-83028967	Weak transcription Enhancers Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs560840669	chr16:83028976-83028977	Weak transcription Enhancers Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs528043538	chr16:83028981-83028982	Weak transcription Enhancers Genic enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs76011651	chr16:83029017-83029018	Weak transcription Enhancers Flanking Active TSS Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs142654428	chr16:83029064-83029065	Weak transcription Enhancers Flanking Active TSS Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs150584783	chr16:83029098-83029099	Weak transcription Enhancers Flanking Active TSS Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs550356333	chr16:83029100-83029101	Weak transcription Enhancers Flanking Active TSS Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs373736606	chr16:83029121-83029122	Weak transcription Enhancers Flanking Active TSS Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs115570852	chr16:83029143-83029144	Weak transcription Enhancers Flanking Active TSS Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs183133916	chr16:83029144-83029145	Weak transcription Enhancers Flanking Active TSS Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs539257431	chr16:83029152-83029153	Weak transcription Enhancers Flanking Active TSS Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs74429987	chr16:83029157-83029158	Weak transcription Enhancers Flanking Active TSS Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs566774298	chr16:83029162-83029163	Weak transcription Enhancers Flanking Active TSS Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs535467122	chr16:83029193-83029194	Weak transcription Enhancers Flanking Active TSS Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs537324841	chr16:83029198-83029199	Weak transcription Enhancers Flanking Active TSS Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs555761405	chr16:83029201-83029202	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs575807555	chr16:83029222-83029223	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs551485773	chr16:83029255-83029256	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs549277002	chr16:83029262-83029263	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a
50	rs187992092	chr16:83029277-83029278	Weak transcription Enhancers Flanking Active TSS Active TSS	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:74)

Disease	PMID	Source
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Autism	19415332	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Schizophrenia	22958593	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Autism	22495311	CNVD
Wilms tumour	21544195	CNVD
Prostate cancer	18632612	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	17850661	CNVD
Breast cancer	16702952	CNVD
Medulloblastoma	16968546	CNVD
Prostate cancer	19242612	CNVD
Cancer	22429812	CNVD
Ewing''s sarcoma	21437220	CNVD
Ewing''s sarcoma	22429812	CNVD
Melanoma	18172304	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	20837533	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Multiple myeloma	21628407	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	21858162	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Ewing''s sarcoma	17952124	CNVD
Breast cancer	17001317	CNVD
Breast cancer	17133270	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Breast cancer	17603634	CNVD
Prostate cancer	16573809	CNVD
Prostate cancer	17245344	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
High-grade prostatic intraepithelial neoplasia	16573809	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Medulloblastoma	16783165	CNVD
Breast cancer	21806811	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
Hepatocellular carcinoma	16750200	CNVD
Breast cancer	21509527	CNVD
Breast cancer	21364760	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Autism	21865298	CNVD
Non-small cell lung cancer	21829676	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Colorectal cancer	16272173	CNVD
Prostate cancer	16461572	CNVD
Melanoma	20688739	CNVD
Myelofibrosis	22110671	CNVD
Alveolar capillary dysplasia	19500772	CNVD
VACTERL syndrome	21315191	CNVD
T-cell lymphomas	19863542	CNVD
Developmental delay	19490664	CNVD
Neuroblastoma	18923191	CNVD
Adrenocortical carcinoma	18281524	CNVD
Developmental delay	21147756	CNVD
Breast cancer	22522925	CNVD
Schizophrenia	23813976	CNVD
Autism	22495309	CNVD

Chromatin state (count:144 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr16:82989800-83029600	Weak transcription	HMEC	breast
2	chr16:83009000-83029400	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
3	chr16:83014800-83030400	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
4	chr16:83017800-83028800	Weak transcription	Left Ventricle	heart
5	chr16:83019600-83029600	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
6	chr16:83021600-83029400	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
7	chr16:83021600-83035200	Weak transcription	Psoas Muscle	Psoas
8	chr16:83021800-83028800	Weak transcription	NHDF-Ad	bronchial
9	chr16:83021800-83029000	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
10	chr16:83021800-83029200	Weak transcription	NHEK	skin
11	chr16:83021800-83035000	Weak transcription	Aorta	Aorta
12	chr16:83024000-83029200	Weak transcription	Osteobl	bone
13	chr16:83024200-83028600	Weak transcription	NH-A	brain
14	chr16:83024200-83029400	Weak transcription	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
15	chr16:83024200-83029600	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
16	chr16:83024200-83030400	Enhancers	Fetal Intestine Small	intestine
17	chr16:83024400-83029200	Weak transcription	Muscle Satellite Cultured Cells	--
18	chr16:83024400-83029400	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
19	chr16:83024400-83029800	Enhancers	Fetal Intestine Large	intestine
20	chr16:83025800-83028800	Weak transcription	Rectal Mucosa Donor 29	rectum
21	chr16:83026400-83029000	Enhancers	Duodenum Mucosa	Duodenum
22	chr16:83027000-83028600	Weak transcription	Rectal Mucosa Donor 31	rectum
23	chr16:83027800-83028800	Enhancers	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
24	chr16:83027800-83028800	Weak transcription	Right Ventricle	heart
25	chr16:83028000-83029400	Weak transcription	HSMMtube	muscle
26	chr16:83028200-83028800	Weak transcription	HSMM	muscle
27	chr16:83028200-83029200	Enhancers	HUVEC	blood vessel
28	chr16:83028600-83029200	Enhancers	Rectal Mucosa Donor 31	rectum
29	chr16:83028600-83029400	Enhancers	NH-A	brain
30	chr16:83028800-83029000	Enhancers	Rectal Mucosa Donor 29	rectum
31	chr16:83028800-83029000	Enhancers	Small Intestine	intestine
32	chr16:83028800-83029000	Flanking Active TSS	NHDF-Ad	bronchial
33	chr16:83028800-83029200	Enhancers	Left Ventricle	heart
34	chr16:83028800-83029200	Genic enhancers	HSMM	muscle
35	chr16:83028800-83029400	Enhancers	Sigmoid Colon	Sigmoid Colon
36	chr16:83028800-83029600	Enhancers	Fetal Adrenal Gland	Adrenal Gland
37	chr16:83028800-83029800	Enhancers	Right Ventricle	heart
38	chr16:83028800-83030000	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
39	chr16:83029000-83029200	Flanking Active TSS	Rectal Mucosa Donor 29	rectum
40	chr16:83029000-83029200	Enhancers	Skeletal Muscle Female	skeletal muscle
41	chr16:83029000-83029400	Flanking Active TSS	Duodenum Mucosa	Duodenum
42	chr16:83029000-83029400	Enhancers	NHDF-Ad	bronchial
43	chr16:83029000-83030600	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
44	chr16:83029200-83029600	Enhancers	Muscle Satellite Cultured Cells	--
45	chr16:83029200-83029600	Enhancers	HSMM	muscle
46	chr16:83029200-83029600	Flanking Active TSS	HUVEC	blood vessel
47	chr16:83029200-83029600	Enhancers	Osteobl	bone
48	chr16:83029200-83030000	Active TSS	Rectal Mucosa Donor 29	rectum
49	chr16:83029200-83030200	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
50	chr16:83029200-83030200	Flanking Active TSS	Rectal Mucosa Donor 31	rectum

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links